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S-acylation of the Insulin-
Responsive Aminopeptidase 
(IRAP): Quantitative analysis and 
ƤƤ
ǤƬǤ
ǦȋȌƤSǦ
ǤǡS-acylation 
ǡƤǡơSǦǤ
ǡǦǦ ? ? ?
IRAP is SǦ ? ?Ǧ ?ǤǡSǦ
 ?ǡ
ǦǡƤǦǤǦ
employed to map the sites of SǦǡ

ǢƤ
ǦǤSǦƥ
ǡơƤ
 娃? ?ǡS-acylation is not essential 
Ǥ
Protein S-acylation (also referred to as palmitoylation) is a post-translational modiication (PTM) involv-
ing the attachment of palmitate and other fatty acids to cysteine residues of proteins via thioester linkage. 
Numerous studies have demonstrated that S-acylation can mediate membrane attachment of soluble 
proteins, and regulate the intracellular traicking of both soluble and transmembrane proteins and their 
partitioning into membrane micro-domains such as lipid rats1. Furthermore, S-acylation can also afect 
protein-protein interactions and protein stability2.
S-acylation is mediated by a family of membrane-bound enzymes comprising 24 isoforms in mam-
mals3,4. hese palmitoyl-transferases (PATs) are referred to as zDHHC enzymes due to the presence 
of a conserved DHHC (Asp-His-His-Cys) amino acid motif present within a zinc-inger cysteine-rich 
domain5–7. Unlike other lipid modiications, S-acylation is reversible and dynamic due to the labile nature 
of the thioester bond8. Depalmitoylation is catalysed by enzymes including acyl-protein thioesterases 
(APTs)9, and cycles of S-acylation and deacylation play an important role in regulating dynamic changes 
in protein localisation, oten in response to speciic signals10,11.
Insulin-stimulated translocation of GLUT4 storage vesicles (GSVs) to the plasma membrane in adi-
pocytes and skeletal muscle cells is essential for blood glucose homeostasis12, and defects in this pathway 
are linked to obesity and diabetes13,14. he insulin-stimulated translocation of GLUT4 to the plasma 
membrane is regulated by various PTMs, most notably phosphorylation. In addition, some studies have 
also highlighted the potential involvement of S-acylation in these pathways. A variety of important 
proteins including the insulin receptor and the SNARE protein SNAP23 have long been known to be 
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S-acylated15,16. More recent studies identiied additional targets of the S-acylation machinery in adipo-
cytes, including GLUT4 and the insulin-responsive aminopeptidase (IRAP)17, a protein that co-localises 
extensively with GLUT4 and regulates the formation and/or traicking of insulin-responsive GLUT4 
storage vesicles18. S-acylation was recently suggested to occur at a single site on GLUT4 (Cys223) and this 
modiication may be involved in the sorting of GLUT4 to insulin-responsive vesicles19. Unlike GLUT4, 
which has a highly restricted expression to adipocytes and skeletal and cardiac muscle, IRAP is expressed 
widely, including in the brain20. At present, the sites of S-acylation on IRAP or how this modiication 
afects the localisation of the protein are not known. Furthermore, there is no information on the likely 
extent of S-acylation of IRAP and how this compares with proteins such as GLUT4.
Results
    Ǧ   ? ?Ǧ ? Ǥ To generate information on 
the extent of IRAP S-acylation, we optimised acyl-RAC (resin-assisted capture) to allow the percent-
age S-acylation of proteins to be estimated by comparing immunoreactivity in equivalent amounts of 
unbound and bound fractions. Diferentiated 3T3-L1 adipocytes were incubated overnight in medium 
containing 5.55 mM D-Glucose, and subsequently total membrane proteins were isolated and subjected 
to acyl-RAC to enrich S-acylated proteins21. his procedure allows the capture of S-acylated proteins on 
thioreactive sepharose following the removal of S-acyl chains by 0.5 M hydroxylamine (HA) treatment. 
As a control, membrane fractions in parallel samples were treated with 0.5 M Tris. When performing 
acyl-RAC, we recovered bound and unbound fractions in equal volumes and resolved the same volume 
of each fraction by SDS-PAGE. his enabled a semi-quantitative assessment of the percentage S-acylation 
of speciic proteins that were detected by immunoblotting. As controls, we analysed Flotillin-2, a known 
S-acylated protein22, and Syntaxin 4, a transmembrane protein that has not been reported to be modiied 
by S-acylation. Whereas ~96% of Flotillin-2 was estimated to be S-acylated by applying this method, 
the fraction of syntaxin 4 recovered as an S-acylated protein was only 3.9% (Fig. 1). Analysis of IRAP 
immunoreactivity in the recovered fractions was consistent with ~60% of this protein being S-acylated, 
whereas the level of S-acylation of GLUT4 was estimated to be less than 12% (Fig. 1).
IRAP is SǦ           -
Ǥ IRAP contains 1,025 amino acids but only the N-terminal 110 amino acids 
are cytoplasmic, with a single transmembrane domain (TMD) predicted to start at amino acid 
Figure 1. Semi-quantitative analysis of IRAP S-acylation in 3T3-L1 adipocytes. On day 9 following 
initiation of the cell diferentiation protocol, 3T3-L1 cells were incubated overnight in media containing 
5.55 mM D-glucose. Cell membranes were then recovered by centrifugation and incubated with MMTS 
(1.5% v/v), and then with either 0.5 M hydroxylamine (HA) or 0.5 M Tris together with free thiol group 
binding beads. Let panel: Recovered fractions were analysed by immunoblotting with the indicated 
antibodies. Position of molecular weight standards are shown on the let. Equivalent amounts of unbound 
and bound fractions were loaded, whereas the input sample was loaded at half this amount. Right panel: 
Quantiication of S-acylation levels of proteins was determined using densitometry of immunoblots shown 
in panel A (n = 3).
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109/110 (mouse/human sequences; Uniprot). Integral membrane proteins are often S-acylated at 
cysteines present at a juxtamembrane position or in the cytosolic end of transmembrane sequences. 
Two cysteines were of particular interest as potential S-acylation sites: Cys-103 and Cys-114, both 
of which are highly conserved and present in or around the TMD (Fig.  2). To investigate if these 
residues are important for S-acylation of IRAP, we generated an HA-tagged form of the protein 
and transfected this or the following cysteine mutants into HEK293T cells: C103A, C114A, C103A/
C114A and C35A/C103A/C114A. The C35A/C103A/C114A triple mutant was included in the anal-
ysis as it lacks any cysteines in the cytoplasmic region of the protein. HEK293T cells were used 
rather than 3T3-L1 adipocytes as they are more amenable to transfection and S-acylation analysis. 
Combined mutation of both C103A and C114A led to a complete loss of IRAP S-acylation, as 
detected using click chemistry with 17-ODYA (Fig.  3). Interestingly however, individual mutation 
of either Cys-103 or Cys-114 had little effect on the amount of labelling of IRAP by 17-ODYA. 
The control sample (non-transfected cells) confirmed the identity of the bands detected by the HA 
antibody.
  SǦ          
 娃? ?Ǥ S-acylation can modulate the intracellular targeting of both transmembrane proteins 
and soluble proteins. To investigate the efect of S-acylation on the traicking of IRAP, we compared the 
localisation of wild-type and 3CA mutant (C35A/C103A/C114A). hese HA-tagged IRAP constructs 
were co-transfected into HEK293T cells with GLUT4-EGFP to provide a co-localising reference protein. 
As shown in Fig.  4A, there was no obvious diference in the localisation of wild-type or 3CA mutant 
IRAP relative to GLUT4-EGFP, and both IRAP proteins showed detectable staining of the plasma mem-
brane. To compare more closely the plasma membrane localisation of wild-type and 3CA mutant IRAP 
in cell populations, transfected cells were treated with trypsin to digest cell surface-exposed proteins. 
To test for the expected efects of trypsin, we examined endogenous zDHHC5, a plasma membrane 
enzyme23. Figure 4B shows that trypsin treatment led to a loss of zDHHC5 immunoreactivity, whereas 
little efect was observed on actin levels (conirming that trypsin does not enter cells). Trypsin treatment 
also led to a marked loss in immunoreactivity of both wild-type and mutant IRAP (Fig. 4B), implying 
that both proteins are expressed at the plasma membrane at similar levels, in agreement with the immu-
noluorescence analysis (Fig. 4A).
Discussion
he high level of constitutive S-acylation of IRAP (~60% by our analysis) suggests that this modiica-
tion is likely to be important for a fundamental property of the protein. Interestingly, a smaller pool 
of GLUT4 was estimated to be S-acylated (< 12%). As S-acylation has been suggested to regulate the 
intracellular traicking of GLUT419, it will be interesting in follow-up work to investigate if this modii-
cation is diferentially regulated on GLUT4 and IRAP. For example, if the S-acylation of GLUT4 is highly 
reversible then this may account for the lower levels of this protein recovered in acyl-RAC fractions. It 
Figure 2. Alignment of the N-terminal sequences of IRAP from human, mouse, rat, Xenopus and 
zebraish. Identical amino acids are highlighted by asterisks, similar amino acids are highlighted by dots. 
Cysteine-103 and cysteine-114 are highlighted by boxes. he amino acids predicted to form the start of the 
transmembrane domain are highlighted by red shading.
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is also possible that the existence of S-acylated and non-acylated pools of GLUT4 is linked to diferent 
subcellular pools of the protein, and this also merits further investigation. Notwithstanding these issues, 
the marked diference in the estimated S-acylation levels of two proteins that co-localise extensively in 
adipocytes highlights the importance of optimising acyl-RAC or acyl-biotin exchange (ABE) experi-
ments to allow an assessment to be made of the likely extent of S-acylation of proteins of interest. A 
potential caveat relating to the quantitative aspect of this work is that we compared unbound and bound 
fractions and it is possible that some protein is lost during the wash steps of the acyl-RAC procedure. 
We preferred to compare the bound fraction to the unbound fraction for the quantitative analysis as 
these samples have been subjected to the same bufer conditions and overnight incubation conditions 
Figure 3. Mapping of S-acylation sites in IRAP. HEK293T cells were transfected with plasmids encoding 
the indicated HA-tagged IRAP constructs for 24 h. Cells were then metabolically labelled with 15 µ M 17-
ODYA and incorporation of 17-ODYA into IRAP was detected by reaction with IRDye 800CW azide. 
Samples were subjected to SDS-PAGE and analysed by immunoblotting. Anti-HA antibody binding and 
IRDye were visualised using a LICOR Odyssey infrared imaging system. A Representative images showing 
17-ODYA incorporation into wild-type and mutant IRAP (top panel), HA immunoreactivity (middle panel) 
and a merge (bottom panel). Position of molecular weight markers are shown on the let. B Quantiication 
of 17-ODYA incorporation into IRAP constructs. Quantiied values of the 17ODYA signal from IRAP 
constructs were normalised to protein expression level. he calculated value of 17-ODYA incorporation into 
wild type IRAP was set to 1 and all mutants were expressed relative to this. One way ANOVA followed by 
Tukey’s multiple comparison test was applied for statistical analysis. ***P ≤ 0.001 (n = 5).
www.nature.com/scientificreports/
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Figure 4. Intracellular localisation of wild-type and cysteine mutant IRAP. A HEK293T cells were co-
transfected with HA-tagged IRAP constructs together with GLUT4-EGFP. Ater 24 h, cells were ixed in 4% 
formaldehyde and subsequently permeabilised with Triton X-100. Cells were then incubated in HA antibody 
and subsequently in secondary antibody conjugated to Alexa Fluor 543. Cells were mounted in ProLong 
Gold Antifade mounting medium containing DAPI. Whole cell image stacks were acquired by confocal 
microscopy. Representative sections of a typical cell are shown. Separate channels displaying GLUT4-EGFP 
(green) and HA-tagged IRAP WT or 3CA mutant (red) and a merge of both channels including DAPI 
staining are shown. Scale bar = 5 µ m. B Cells were transfected for 24 h with plasmids encoding  
HA-tagged IRAP wild type or cysteine to alanine mutant (3CA) and were incubated in trypsin-EDTA 
(0.05%) (+ ) or in standard culture media (–) for 30 minutes. Cell lysates were subjected to SDS-PAGE 
followed by immunoblotting with the indicated antibodies. Anti-HA was used for detection of HA-IRAP. 
Samples were loaded in duplicate and representative immunoblots are shown, with the position of molecular 
weight markers indicated on the let hand side of blots.
www.nature.com/scientificreports/
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(see Methods). Interestingly, Ren et al.17 suggested that IRAP S-acylation was likely to be higher than 
S-acylation of Munc18c based on a qualitative comparison of bound and input samples. his suggestion 
is consistent with the observations made in the current study.
he double cysteine mutant (C103/114A) of IRAP displayed a near complete loss of incorpora-
tion of 17-ODYA but individual mutation of the cysteines had little efect on incorporation (Fig.  3). 
Hence, although the cysteine residue pair consisting of cysteine-103 and cysteine-114 is essential for 
IRAP S-acylation, there appears to be a complex relationship between these residues. We suggest that 
IRAP might be constitutively S-acylated on either Cys-103 or Cys-114 in a mutually exclusive manner. 
S-acylation at a single site might modify the structure or membrane topology of IRAP, preventing mod-
iication of the other cysteine. Alternatively, both cysteines might be S-acylated in the wild-type protein 
and mutation of one of these sites might make the other site more accessible to its respective zDHHC 
enzyme, increasing the rate of S-acylation at that site. Another possibility is that mutation of individual 
cysteines decreases the rate of deacylation of the other cysteine. Interestingly, a similar observation was 
made for the lipoprotein receptor-related proteins 6 (LRP6), which shares a common membrane topol-
ogy to IRAP with a single TMD and two cysteines in proximity to the TMD. Simultaneous replacement 
of both of these cysteines in LRP6 to alanine resulted in a substantial loss of S-acylation, but individual 
cysteine replacement had almost no efect24.
At present, we do not know how S-acylation exerts regulation on IRAP. his modiication did not 
appear to be required for plasma membrane targeting of the protein in HEK293T cells or for co-localisation 
with GLUT4 in these cells. IRAP is widely expressed and we also detected similar levels of S-acylation of 
the protein in rat brain. hus, the analysis of IRAP localisation in HEK293T cells is valid. Nevertheless, it 
would also be of interest to examine if there is a speciic requirement for S-acylation in the targeting of 
IRAP to insulin-responsive compartments in adipocyte, as was suggested recently for GLUT419. Such a 
role would place S-acylation (and the enzymes that control this process) as an important factor required 
for eicient formation/traicking of GLUT4 storage vesicles.

 Ǥ A plasmid containing mouse IRAP cDNA was synthesised and supplied by 
GeneArt® . his cDNA included a sequence encoding a triple HA-tag upstream of the IRAP coding 
sequence. his HA-IRAP construct was lanked by SalI and BamHI restriction sites to facilitate cloning 
into the EGFP-N1 vector (the presence of a stop codon in IRAP prevented translation of the downstream 
EGFP sequence). Cysteine residues at positions 35, 103 and 114 were mutated to alanine individually or 
in combination by site-directed mutagenesis.
GLUT4 was ampliied from 3T3-L1 adipocyte cDNA and cloned into pEGFP-N1 using HindIII and 
SalI restriction sites.
Ǥ Monoclonal Flotillin-2 and monoclonal IRAP antibodies were obtained from Cell 
Signalling (MA, USA). GLUT4 antibody was from Abcam (Cambridge, UK). Anti-Syntaxin 4 rabbit 
polyclonal antibody was purchased from Synaptic Systems (Goettingen, Germany). zDHHC5 antibody 
was from Sigma (Poole, UK). Anti-HA rat monoclonal antibody was purchased from Roche (Basel, 
Switzerland).
Ǥ Mouse 3T3-L1 adipocytes were cultured in Dulbecco’s Modiied Eagle Medium (DMEM) 
GlutaMAX™ , supplemented with 10% newborn calf serum and 1% penicillin/streptomycin. Controlled 
conditions were maintained in a humidiied cell incubator set to a temperature of 37 OC and contain-
ing 10% CO2. he diferentiation of 3T3-L1 cells into adipocytes was induced by adding diferentiation 
media consisting of DMEM GlutaMAX™ containing 10% fetal bovine serum, 1% penicillin/strepto-
mycin, insulin (170 nM), troglitazone (1 µ M), 3-isobutyl-1-methylxanthine (IBMX) (500 µ M) and dexa-
methasone (0.25 µ M) to pre-adipocytes that had been conluent for approximately 48 h. Ater three days 
the media was replaced with diferentiation media without IBMX and dexamethasone. Adipocytes were 
used 9 days following the start of the diferentiation protocol.
HEK293T cells were cultured in DMEM containing 10% fetal bovine serum in a humidiied incubator 
at 37 °C and 5% CO2. Cells were transfected using Lipofectamine 2000 according to the manufacturer’s 
instructions (Life Technologies).
ǦǤ Prior to harvesting, 3T3-L1 adipocytes were incubated overnight in medium contain-
ing 5.55 mM D-Glucose. Subsequently, cells were collected in bufer A (25 mM HEPES, 25 mM NaCl, 
1 mM EDTA, pH 7.4 and protease inhibitor cocktail) and passed ive to ten times through a 26G needle. 
Following disruption, the cell fraction was centrifuged at 800 × g for 5 minutes at 4 °C, and the recovered 
supernatant was then subjected to an additional centrifugation step at 136,000 × g for 60 min at 4 °C. he 
pellet containing the membrane fraction was then resuspended in 100 µ l bufer A containing 0.5% Triton 
X-100 (v/v). In order to block free SH groups with S-methyl methanethiosulfonate (MMTS), 200 µ l of 
blocking bufer (100 mM HEPES, 1 mM EDTA, 87.5 mM SDS and 1–1.5% (v/v) MMTS) was added to 
the resuspended proteins and incubated for 4 h at 40 °C with frequent vortexing. Subsequently, 3 vol-
umes of ice-cold 100% acetone was added to the blocking protein mixture and incubated for 20 minutes 
at − 20 °C and then centrifuged at 5,000 × g for 10 minutes at 4 °C to pellet precipitated proteins. he 
www.nature.com/scientificreports/
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pellet was washed ive times in 1 ml of 70% (v/v) acetone and resuspended in bufer B (100 mM HEPES, 
1 mM EDTA, 35 mM SDS). A fraction of the solubilised pellet was saved as the input. For treatment 
with hydroxylamine (HA) and capture by hiopropyl Sepharose® beads, 2 M HA was added together 
with the beads (previously activated for 15 min with dH2O) to a inal concentration of 0.5 M HA and 
10% (w/v) beads. As a negative control, 2 M Tris was used instead of HA. hese samples were then 
incubated overnight at room temperature with end-over-end mixing. he supernatant was removed and 
retained as the “unbound” fraction. he remaining beads were washed ive times with 1 ml bufer B. 
Subsequently, the proteins were eluted from the beads by two consecutive incubations in 100 µ l SDS 
sample bufer containing 50 mM dithiothreitol (DTT) for 15 minutes at room temperature and then 
5 minutes at 95 °C. he eluted proteins were the “bound” fraction. Before subjecting all samples to 
SDS-PAGE, the inal volumes of the bound and unbound fractions were equalised. For quantiication 
of S-acylation, we used the following equation: [Bound(HA)/(Bound(HA) + Unbound(HA)] − [Bound 
(Tris)/(Bound(Tris) + Unbound(Tris)].
    Ǥ HEK293T on 24-well plates were transfected with 1 µ g 
plasmid per well. 24 h post-transfection, cells were incubated in serum-free medium containing 1% (w/v) 
fatty acid-free bovine serum albumin (BSA) for 30 minutes. For metabolic labelling, cells were incubated 
in serum-free culture medium containing 1% (w/v) fatty acid-free BSA and 15 µ M 17ODYA for 4 hours. 
All incubations of the cells were carried out in a cell culture incubator with saturated humidity, 5% CO2 
and at 37oC. Subsequently, cells were lysed in 100 µ l of click-chemistry lysis bufer (50 mM Tris, 17 mM 
SDS, pH 8.0 containing protease inhibitors). For the click-reaction, 80 µ l of click-reaction mix (5 mM 
CuSO4, 500 µ M Tris(benzyltriazolylmethyl)amine (TBTA), 25 µ M IRDye 800 CW azide) was added to 
the lysed cells and vortexed. his was then immediately supplemented with 20 µ l of ascorbic acid (4 mM) 
and incubated for one hour at room temperature with end-over-end mixing. Following the click-reaction 
three volumes of ice-cold 100% acetone was added and incubated at − 20 °C for 20 minutes. Precipitated 
proteins were pelleted by centrifugation for 5 minutes at 13,000 x g and 4 °C, washed 3 times in 70% 
ice-cold acetone and centrifuged each time for 5 minutes at 13,000 × g at 4 °C. he pellet was then dis-
solved in 100 µ l SDS sample bufer with 25 mM DTT and heated for 5 minutes at 95 °C. he samples were 
then analysed by SDS-PAGE and immunoblotting.
   Ǧ  Ǥ HEK293T cells transfected for 24 h 
with plasmids encoding the protein of interest (1 µ g/well of a 6-well plate) were washed with PBS, and 
then incubated in trypsin-EDTA solution (0.05%) or HEK293T culture media (control) for 30 min in 
a cell culture incubator at 37 °C/5% CO2. Subsequently, the cells were transferred into eppendorf tubes 
and pelleted by centrifugation. he cell pellets were then washed twice by adding 1 ml PBS followed by 
centrifugation, resuspended in 200 µ l SDS sample bufer with 25 mM DTT and subjected to SDS-PAGE 
followed by immunoblotting.
Ǥ Transfected cells were washed twice with PBS and ixed in 4% (v/v) of formal-
dehyde for 30 minutes at room temperature. he ixed cells were washed in PBS containing 0.3% BSA 
(PBS-BSA) and then permeabilised in PBS-BSA containing 0.25% Triton X-100 for 10 min. Permeabilised 
cells were washed in PBS-BSA and incubated in HA antibody (1:50 in PBS-BSA) for 60 min. he cells 
were washed again in PBS-BSA to remove free HA antibody and then incubated for 60 min in PBS-BSA 
containing anti-mouse antibody conjugated to Alexa Fluor 543 dye (1:400). he cells were then washed 
in PBS, air-dried and mounted onto microscope slides using ProLong Gold Antifade Reagent with DAPI 
(4’,6-Diamidino-2-Phenylindole) mounting medium (Life Technologies (Paisley, U.K.)). A Leica SP5 
Confocal Laser Scanning Microscope was used for image acquisition. Image stacks were deconvolved 
using Huygen’s sotware.
Ǥ he sotware Image Studio™ Lite V3.1 (LI-COR Biosciences, Lincoln, NE, U.S.A.) was 
used for quantiication of immunoblots. he mean of the measured values was presented with the stand-
ard error of the mean (SEM). To assess statistical signiicance, a one-way analysis of variance (ANOVA) 
in conjunction with a Tukey’s Test was performed (GraphPad Prism® sotware).
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